Many of the greatest successes in oncology come from more careful understanding of the
oncogenic mechanism of disease, resulting in intervention with either prevention …

Background Immunodeficiency syndromes (acquired/congenital/iatrogenic) are known to
increase Hodgkin lymphoma (HL) risk, but the effects of allergic immune dysregulation and …

10526 Background: Hodgkin's Lymphoma (HL) is the commonest cancer in teenagers and
young adults (TYAs). Incidence in this age group has been increasing since the early 1990s …

Hodgkin lymphoma (HL) is a rare malignancy of the lymphatic system that is curable in at
least 80% of patients. Although patients usually present with painless lymphadenopathy, a …

Hodgkin's lymphoma (HL) is a lymphoproliferative malignancy of B-cell origin, with an age-
adjusted incidence of 2.3-3.1 per 100,000 in the Western world. 1 HL is subdivided into …

Introduction: In epidemiological studies, chronic inflammation or previous major infection
have revealed to be associated with an increased risk of developing Hodgkin lymphoma …

Epidemiologic and molecular findings suggest that classical Hodgkin's lymphoma (CHL) is
not a single disease but consists of more than one entity and may occur in different clinical …

multiple extranodal sites or LNs and extranodal disease. The A or B designation is then
assigned according to the absence or presence of symptoms (weight loss, fever, drenching …

Abstract Background: Patients with classical Hodgkin lymphoma (cHL) often present with
asymptomatic lymphadenopathy or generalized symptoms including fevers, night sweats, or …

The consequences of HL treatments on thymus involution remain poorly explored. 2 Here,
we investigated the long-term effects of thymic irradiation on the naive T-cell compartment in …